CAS 2095393-15-8

ARQ 531

CAS: 2095393-15-8

ARQ-531: potent oral BTK inhibitor, anti-cancer potential, IC50 of 0.85/0.39 nM for WT/C481S-BTK.

Formula: C₂₅H₂₃ClN₄O₄

Purity: 98.68% - 99.63%

Color and Shape: Solid

Molecular weight: 478.93

Ref: TM-T14323

1,​5-​Anhydro-​2-​[[5-​(2-​chloro-​4-​phenoxybenzoyl)​-​7H-​pyrrolo[2,​3-​d]​pyrimidin-​4-​yl]​amino]​-​2,​3,​4-​trideoxy-​D-​erythro-​hexitol

CAS: 2095393-15-8

Formula: C₂₅H₂₃ClN₄O₄

Purity: 99%

Color and Shape: Solid

Molecular weight: 478.9275

Ref: IN-DA01EO8E

ARQ 531

CAS: 2095393-15-8

ARQ 531

Purity: ≥98%

Molecular weight: 478.93g/mol

Ref: 54-BUP09823

ARQ 531

Controlled Product

CAS: 2095393-15-8

Formula: C₂₅H₂₃ClN₄O₄

Color and Shape: Neat

Molecular weight: 478.928

Ref: TR-A158920

ARQ 531

CAS: 2095393-15-8

ARQ 531 is a small molecule inhibitor specifically designed to target Bruton's tyrosine kinase (BTK), which is a type of enzymatic protein. This compound is meticulously developed within a laboratory setting to disrupt key pathways involved in cancer cell survival. Its mode of action involves the selective and reversible inhibition of BTK, thereby obstructing signal transduction that promotes malignant cell proliferation and survival.

Formula: C₂₅H₂₃ClN₄O₄

Purity: Min. 95%

Molecular weight: 478.93 g/mol

Ref: 3D-VID39315